MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$12.97−0.85 (-6.15%)
Close on Nov 12, 2026Market cap $166.47MP/E –Yield –
MediWound EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$2.10. The highest annual figure on record is $1.26 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.10 | – |
| FY2024 | Dec 31, 2024 | -$3.03 | – |
| FY2023 | Dec 31, 2023 | -$0.75 | – |
| FY2022 | Dec 31, 2022 | -$3.93 | – |
| FY2021 | Dec 31, 2021 | -$3.48 | – |
| FY2020 | Dec 31, 2020 | -$2.38 | -288.9% |
| FY2019 | Dec 31, 2019 | $1.26 | – |
| FY2018 | Dec 31, 2018 | -$0.28 | – |
| FY2017 | Dec 31, 2017 | -$6.65 | – |
| FY2016 | Dec 31, 2016 | -$6.02 | – |
| FY2015 | Dec 31, 2015 | -$7.14 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.77 | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.23 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.68 | – |
| Q2 FY2023 | Jun 30, 2023 | $0.10 | -97.0% |
| Q2 FY2022 | Jun 30, 2022 | -$0.92 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.84 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.77 | – |
| Q2 FY2019 | Jun 30, 2019 | $3.29 | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.05 | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.40 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?